Screening for the presence of FMR1 premutation alleles in women with parkinsonism

Roberto Cilia, Jeremy Kraff, Margherita Canesi, Gianni Pezzoli, Stefano Goldwurm, Khalid Amiri, Hiu Tung Tang, Ruiqin Pan, Paul J Hagerman, Flora Tassone

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Background: Fragile X-associated tremor/ataxia syndrome (FXTAS) is a progressive, late-onset neurodegenerative disease that affects older carriers of premutation (CGG) repeat expansions of the fragile X mental retardation 1 (FMR1) gene. Clinical features include intention tremor, gait ataxia, memory loss, peripheral neuropathy, autonomic dysfunction, and parkinsonism. The presence of parkinsonism in FXTAS raises the possibility that some individuals who have Parkinson disease are actually carriers of a premutation FMR1 allele. Objective: To screen DNA samples from a large cohort of females with Parkinson disease for an excess of expanded alleles of the FMR1 gene. Design and Patients: We screened a cohort of 595 women with parkinsonism, the largest screening of a par- kinsonism-associated group to date, for the presence of an FMR1 premutation allele (55-200 CGG repeats). The screening protocol uses an enhanced polymerase chain reaction method capable of flagging any FMR1 expanded CGG repeat in women as well as in men. Setting: Diagnostic assessments were performed at an outpatient tertiary clinic (Parkinson Institute, Milan). Genotyping was conducted at the University of California, Davis. Main Outcome Measures: CGG repeat number and clinical/neuroimaging assessments of patients with Parkinson disease were conducted. Two premutation carriers were identified. Results: Two individuals possessed an FMR1 allele in the premutation range (CGG repeats: 30 and 75; 30 and 115). This carrier frequency (2 of 595 [0.34%]) is not significantly different from estimates of the allele frequency among women in the general population (0.4%- 0.8%). Clinical and radiologic features of these 2 patients were similar to those of the general Parkinson disease population; however, 1 patient (115 CGG repeats) had a family history of 2 sons with the fragile X syndrome. Conclusion: Screening of women within the parkinson- ism clinical spectrum is unlikely to be productive in the absence of additional medical or family history suggestive of involvement of the FMR1 gene.

Original languageEnglish (US)
Pages (from-to)244-249
Number of pages6
JournalArchives of Neurology
Volume66
Issue number2
DOIs
StatePublished - Feb 2009

Fingerprint

Parkinsonian Disorders
Intellectual Disability
Alleles
Parkinson Disease
Medical History Taking
Gait Ataxia
Genes
Fragile X Syndrome
Memory Disorders
Peripheral Nervous System Diseases
Tremor
Ambulatory Care Facilities
Screening
Mental Retardation
Allele
Nuclear Family
Gene Frequency
Neuroimaging
Neurodegenerative Diseases
Population

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Screening for the presence of FMR1 premutation alleles in women with parkinsonism. / Cilia, Roberto; Kraff, Jeremy; Canesi, Margherita; Pezzoli, Gianni; Goldwurm, Stefano; Amiri, Khalid; Tang, Hiu Tung; Pan, Ruiqin; Hagerman, Paul J; Tassone, Flora.

In: Archives of Neurology, Vol. 66, No. 2, 02.2009, p. 244-249.

Research output: Contribution to journalArticle

Cilia, R, Kraff, J, Canesi, M, Pezzoli, G, Goldwurm, S, Amiri, K, Tang, HT, Pan, R, Hagerman, PJ & Tassone, F 2009, 'Screening for the presence of FMR1 premutation alleles in women with parkinsonism', Archives of Neurology, vol. 66, no. 2, pp. 244-249. https://doi.org/10.1001/archneurol.2008.548
Cilia, Roberto ; Kraff, Jeremy ; Canesi, Margherita ; Pezzoli, Gianni ; Goldwurm, Stefano ; Amiri, Khalid ; Tang, Hiu Tung ; Pan, Ruiqin ; Hagerman, Paul J ; Tassone, Flora. / Screening for the presence of FMR1 premutation alleles in women with parkinsonism. In: Archives of Neurology. 2009 ; Vol. 66, No. 2. pp. 244-249.
@article{34f51f0a6b39442cb78ac8b6b37cab6d,
title = "Screening for the presence of FMR1 premutation alleles in women with parkinsonism",
abstract = "Background: Fragile X-associated tremor/ataxia syndrome (FXTAS) is a progressive, late-onset neurodegenerative disease that affects older carriers of premutation (CGG) repeat expansions of the fragile X mental retardation 1 (FMR1) gene. Clinical features include intention tremor, gait ataxia, memory loss, peripheral neuropathy, autonomic dysfunction, and parkinsonism. The presence of parkinsonism in FXTAS raises the possibility that some individuals who have Parkinson disease are actually carriers of a premutation FMR1 allele. Objective: To screen DNA samples from a large cohort of females with Parkinson disease for an excess of expanded alleles of the FMR1 gene. Design and Patients: We screened a cohort of 595 women with parkinsonism, the largest screening of a par- kinsonism-associated group to date, for the presence of an FMR1 premutation allele (55-200 CGG repeats). The screening protocol uses an enhanced polymerase chain reaction method capable of flagging any FMR1 expanded CGG repeat in women as well as in men. Setting: Diagnostic assessments were performed at an outpatient tertiary clinic (Parkinson Institute, Milan). Genotyping was conducted at the University of California, Davis. Main Outcome Measures: CGG repeat number and clinical/neuroimaging assessments of patients with Parkinson disease were conducted. Two premutation carriers were identified. Results: Two individuals possessed an FMR1 allele in the premutation range (CGG repeats: 30 and 75; 30 and 115). This carrier frequency (2 of 595 [0.34{\%}]) is not significantly different from estimates of the allele frequency among women in the general population (0.4{\%}- 0.8{\%}). Clinical and radiologic features of these 2 patients were similar to those of the general Parkinson disease population; however, 1 patient (115 CGG repeats) had a family history of 2 sons with the fragile X syndrome. Conclusion: Screening of women within the parkinson- ism clinical spectrum is unlikely to be productive in the absence of additional medical or family history suggestive of involvement of the FMR1 gene.",
author = "Roberto Cilia and Jeremy Kraff and Margherita Canesi and Gianni Pezzoli and Stefano Goldwurm and Khalid Amiri and Tang, {Hiu Tung} and Ruiqin Pan and Hagerman, {Paul J} and Flora Tassone",
year = "2009",
month = "2",
doi = "10.1001/archneurol.2008.548",
language = "English (US)",
volume = "66",
pages = "244--249",
journal = "Archives of Neurology",
issn = "0003-9942",
publisher = "American Medical Association",
number = "2",

}

TY - JOUR

T1 - Screening for the presence of FMR1 premutation alleles in women with parkinsonism

AU - Cilia, Roberto

AU - Kraff, Jeremy

AU - Canesi, Margherita

AU - Pezzoli, Gianni

AU - Goldwurm, Stefano

AU - Amiri, Khalid

AU - Tang, Hiu Tung

AU - Pan, Ruiqin

AU - Hagerman, Paul J

AU - Tassone, Flora

PY - 2009/2

Y1 - 2009/2

N2 - Background: Fragile X-associated tremor/ataxia syndrome (FXTAS) is a progressive, late-onset neurodegenerative disease that affects older carriers of premutation (CGG) repeat expansions of the fragile X mental retardation 1 (FMR1) gene. Clinical features include intention tremor, gait ataxia, memory loss, peripheral neuropathy, autonomic dysfunction, and parkinsonism. The presence of parkinsonism in FXTAS raises the possibility that some individuals who have Parkinson disease are actually carriers of a premutation FMR1 allele. Objective: To screen DNA samples from a large cohort of females with Parkinson disease for an excess of expanded alleles of the FMR1 gene. Design and Patients: We screened a cohort of 595 women with parkinsonism, the largest screening of a par- kinsonism-associated group to date, for the presence of an FMR1 premutation allele (55-200 CGG repeats). The screening protocol uses an enhanced polymerase chain reaction method capable of flagging any FMR1 expanded CGG repeat in women as well as in men. Setting: Diagnostic assessments were performed at an outpatient tertiary clinic (Parkinson Institute, Milan). Genotyping was conducted at the University of California, Davis. Main Outcome Measures: CGG repeat number and clinical/neuroimaging assessments of patients with Parkinson disease were conducted. Two premutation carriers were identified. Results: Two individuals possessed an FMR1 allele in the premutation range (CGG repeats: 30 and 75; 30 and 115). This carrier frequency (2 of 595 [0.34%]) is not significantly different from estimates of the allele frequency among women in the general population (0.4%- 0.8%). Clinical and radiologic features of these 2 patients were similar to those of the general Parkinson disease population; however, 1 patient (115 CGG repeats) had a family history of 2 sons with the fragile X syndrome. Conclusion: Screening of women within the parkinson- ism clinical spectrum is unlikely to be productive in the absence of additional medical or family history suggestive of involvement of the FMR1 gene.

AB - Background: Fragile X-associated tremor/ataxia syndrome (FXTAS) is a progressive, late-onset neurodegenerative disease that affects older carriers of premutation (CGG) repeat expansions of the fragile X mental retardation 1 (FMR1) gene. Clinical features include intention tremor, gait ataxia, memory loss, peripheral neuropathy, autonomic dysfunction, and parkinsonism. The presence of parkinsonism in FXTAS raises the possibility that some individuals who have Parkinson disease are actually carriers of a premutation FMR1 allele. Objective: To screen DNA samples from a large cohort of females with Parkinson disease for an excess of expanded alleles of the FMR1 gene. Design and Patients: We screened a cohort of 595 women with parkinsonism, the largest screening of a par- kinsonism-associated group to date, for the presence of an FMR1 premutation allele (55-200 CGG repeats). The screening protocol uses an enhanced polymerase chain reaction method capable of flagging any FMR1 expanded CGG repeat in women as well as in men. Setting: Diagnostic assessments were performed at an outpatient tertiary clinic (Parkinson Institute, Milan). Genotyping was conducted at the University of California, Davis. Main Outcome Measures: CGG repeat number and clinical/neuroimaging assessments of patients with Parkinson disease were conducted. Two premutation carriers were identified. Results: Two individuals possessed an FMR1 allele in the premutation range (CGG repeats: 30 and 75; 30 and 115). This carrier frequency (2 of 595 [0.34%]) is not significantly different from estimates of the allele frequency among women in the general population (0.4%- 0.8%). Clinical and radiologic features of these 2 patients were similar to those of the general Parkinson disease population; however, 1 patient (115 CGG repeats) had a family history of 2 sons with the fragile X syndrome. Conclusion: Screening of women within the parkinson- ism clinical spectrum is unlikely to be productive in the absence of additional medical or family history suggestive of involvement of the FMR1 gene.

UR - http://www.scopus.com/inward/record.url?scp=60549097218&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60549097218&partnerID=8YFLogxK

U2 - 10.1001/archneurol.2008.548

DO - 10.1001/archneurol.2008.548

M3 - Article

C2 - 19204162

AN - SCOPUS:60549097218

VL - 66

SP - 244

EP - 249

JO - Archives of Neurology

JF - Archives of Neurology

SN - 0003-9942

IS - 2

ER -